Disease: Neurofibromatosis type 2
- A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion
- A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis
- A rare case of schwannomatosis with meningioma: a case report
- Activation of the melanocortin-1 receptor attenuates neuronal apoptosis after traumatic brain injury by upregulating Merlin expression
- An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis
- Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations
- Audiological Outcome of the Simultaneous Tumor Resection and Cochlear Implantation in Two Cases of Sporadic and Two Cases of Neurofibromatosis Type 2-Associated Intracochlear Schwannoma
- Auditory Brainstem Implant Outcomes in Tumor and Nontumor Patients: A Systematic Review
- Auditory brainstem implant: current states and future prospects
- Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis
- Bevacizumab Treatment for Patients with <em>NF2</em>-Related Schwannomatosis: A Single Center Experience
- Bilateral Inferior Rectus Schwannoma and Strabismus: A Case Report
- Bilateral intracochlear schwannomas: histopathological confirmation and outcomes following tumour removal and cochlear implantation with lateral wall electrodes
- Bilateral vestibular schwannoma with a cooccurring meningioma in a child: a case report and review of literature
- Brazilian Society of Otology task force - Vestibular Schwannoma ‒ evaluation and treatment
- Brigatinib in <em>NF2</em>-Related Schwannomatosis with Progressive Tumors
- Cancer Predisposition Syndromes in Neuro-oncology
- Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma
- Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis
- Clavicular window for brachial plexus schwannoma removal
- Clinical practice guideline on the management of vestibular schwannoma
- Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes
- Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis
- CONCENTRIC MACULAR RINGS SIGN IN COMBINED HAMARTOMA OF RETINA AND RETINAL PIGMENT EPITHELIUM
- Death in a bathtub of an adolescent with neurofibromatosis type 2 exhibiting meningioangiomatosis with white matter involvement
- Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
- Extraordinary Speech and Language Outcomes After Auditory Brainstem Implantation: Guidance From a Case Study
- Factors Affecting Speech Discrimination After Vestibular Schwannoma Resection
- Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis
- Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance
- G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells
- Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions
- Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials
- Generation of a zebrafish neurofibromatosis model via inducible knockout of <em>nf2</em>
- Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study
- Hearing Function after CyberKnife for Vestibular Schwannoma: A Systematic Review
- Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis
- Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools
- Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
- Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
- Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis
- Intraoperative assessment of cochlear nerve functionality in various vestibular schwannoma scenarios: Lessons learned
- Is vestibular schwannoma really a benign tumor? Case report and review
- Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
- Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective
- Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2
- Low back pain with axillary mass in a perimenopausal woman: A case of schwannomatosis mimicking metastasis
- Malignant perineurioma derived from the retroperitoneum with an aggressive clinical course: a case report
- Malignant Transformation of Benign Meningiomas with or without Radiotherapy
- Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma
- Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis
- Meningioma
- Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates
- Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration
- Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells
- Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution
- MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas
- Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis
- Navigating Uncharted Waters: Comparative Analysis of Clinical Progression and Outcomes in Vestibular Schwannoma Patients with Papilledema and without Hydrocephalus, Versus Those without Papilledema and Hydrocephalus: A Comprehensive Institutional Insight
- Neurocutaneous Disorders in Pregnancy
- Neurofibromatosis
- Neurofibromatosis Type 1
- Neurofibromatosis type 1: Clinical characteristics and mutation spectrum in a North Indian cohort
- Neurofibromatosis type 2 in the otorhinolaryngological practice
- New classification and approaches to the treatment of schwannomatosis
- NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues
- NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
- Patient Characteristics Impacting Adherence to Serial Observation for Vestibular Schwannomas
- Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials
- PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas
- Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature
- Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
- Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis
- Predictors of clinical and structural outcomes after surgery for spinal nerve sheath tumor resection: a retrospective analysis
- Radiation-Induced Sensorineural Hearing Loss and Potential Management
- Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials
- Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study
- Retinal Ischemia as a Presenting Ocular Sign of Neurofibromatosis Type 2
- Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System
- Schwannomatosis: a Realm Reborn: year one
- Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis
- Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis
- Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments
- Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2
- Sporadic pediatric vestibular schwannoma: a case report in a 4-year-old boy
- Sporadic vestibular schwannoma in a pediatric population: a case series
- Squamous Metaplasia in a Schwannoma: A Unique Histologic Finding
- Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas
- Susceptibility-Weighted MRI for Predicting NF-2 Mutations and S100 Protein Expression in Meningiomas
- Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma
- The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling
- The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis
- The molecular biology of NF2/Merlin on tumorigenesis and development
- TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma
- Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas
- Unilateral Multifocal Inner Ear and Internal Auditory Canal or Cerebellopontine Angle Cochleovestibular Schwannomas-Genetic Analysis and Management by Surgical Resection and Cochlear Implantation
- Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
- Vestibular Schwannoma
- Vestibular schwannoma unveiled by pregnancy: A case report and literature review
- Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients